Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prelude Therapeutics (PRLD) Treasury Shares (2024 - 2025)

Historic Treasury Shares for Prelude Therapeutics (PRLD) over the last 2 years, with Q3 2025 value amounting to $292375.0.

  • Prelude Therapeutics' Treasury Shares rose 30678.26% to $292375.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $292375.0, marking a year-over-year increase of 30678.26%. This contributed to the annual value of $56250.0 for FY2024, which is N/A changed from last year.
  • Per Prelude Therapeutics' latest filing, its Treasury Shares stood at $292375.0 for Q3 2025, which was up 30678.26% from $337750.0 recorded in Q2 2025.
  • In the past 5 years, Prelude Therapeutics' Treasury Shares ranged from a high of $384875.0 in Q1 2025 and a low of $56250.0 during Q4 2024